Literature DB >> 26799788

The transfusion tether: Bridging the gap between end-stage hematologic malignancies and optimal end-of-life care.

Gabriel N Mannis1, Lisa M McNey2, Neel K Gupta3, Dawn M Gross4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26799788     DOI： 10.1002/ajh.24294

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

1.  Advance care planning and end-of-life care for patients with hematologic malignancies who die after hematopoietic cell transplant.

Authors:  E E Eckhert; K L Schoenbeck; D Galligan; L M McNey; J Hwang; G N Mannis
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483

Review 2.  Transfusion as a Palliative Strategy.

Authors:  Jay S Raval
Journal:  Curr Oncol Rep       Date:  2019-08-30       Impact factor: 5.075

3.  Transfusion practices at end of life for hematopoietic stem cell transplant patients.

Authors:  Winnie S Wang; Joseph D Ma; Sandahl H Nelson; Carolyn Revta; Gary T Buckholz; Carolyn Mulroney; Eric J Roeland
Journal:  Support Care Cancer       Date:  2017-12-28       Impact factor: 3.603

4.  Intensity of End-of-Life Care for Patients with Hematologic Malignancies and the Role of Race/Ethnicity.

Authors:  Kedar Kirtane; Lois Downey; Stephanie J Lee; J Randall Curtis; Ruth A Engelberg
Journal:  J Palliat Med       Date:  2018-07-05       Impact factor: 2.947

5.  Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies.

Authors:  Michael J Hochman; Yinxi Yu; Steven P Wolf; Greg P Samsa; Arif H Kamal; Thomas W LeBlanc
Journal:  J Pain Symptom Manage       Date:  2017-09-05       Impact factor: 3.612

6.  A Cohort Study of Patient-Reported Outcomes and Healthcare Utilization in Acute Myeloid Leukemia Patients Receiving Active Cancer Therapy in the Last Six Months of Life.

Authors:  Jared R Lowe; Yinxi Yu; Steven Wolf; Greg Samsa; Thomas W LeBlanc
Journal:  J Palliat Med       Date:  2018-01-17       Impact factor: 2.947

7.  Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study.

Authors:  Nobuyuki Yotani; Daisuke Shinjo; Motohiro Kato; Kimikazu Matsumoto; Kiyohide Fushimi; Yoshiyuki Kizawa
Journal:  BMC Palliat Care       Date:  2021-06-07       Impact factor: 3.234

8.  Sociodemographic and hospital-based predictors of intense end-of-life care among children, adolescents, and young adults with hematologic malignancies.

Authors:  Sophia Mun; Rong Wang; Xiaomei Ma; Prasanna Ananth
Journal:  Cancer       Date:  2021-06-29       Impact factor: 6.921
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.